Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Data from the REVERSE-IT trial provide vital insight into the efficacy and safety of bentracimab as an FDA decision looms on the horizon. 

REVERSE-IT: Bentracimab Effective in Reversing Ticagrelor Antiplatelet Effects

OAC-naive patients experienced a significantly smaller increase in stroke or systemic embolism with asundexian than apixaban.

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

The regulatory agency granted 510(k) clearance to Caristo Diagnostics' image analysis software to aid in coronary artery disease diagnosis.

FDA Clears AI-Assisted CaRi-Plaque Image Analysis for CAD

Our top 5 headlines include 5 key FDA decisions, including the first approval for stroke in 3 decades, an expanded indication for pediatric anaphylaxis, and more!

The HCPFive: Top News for Healthcare Providers from the Week of 03/02

Marking the first stroke medicine approved in nearly 30 years, the single five-second intravenous bolus provides faster administration than the standard of care.

FDA Approves Tenecteplase (TNKase) for Acute Ischemic Stroke

Children who have had a stroke, especially in late primary school, face a greater r risk of anxiety, a study found.

Children Who Experience a Stroke Have a Greater Anxiety Risk

A study found propranolol significantly lowers ischemic stroke risk in women with migraine, highlighting its potential for stroke prevention in high-risk groups.

Propranolol Linked to Lower Ischemic Stroke Risk in Females with Migraine

Siddharth Patel, MD, MPH, discusses how an AZALEA-TIMI 71 analysis presented at ESC Congress 2024.

Siddharth Patel, MD, MPH: Abelacimab Could Help Reduce Procedure-Related Bleeding

Asundexian failed to prove noninferiority to apixaban for its primary efficacy outcome in the phase 3 OCEANIC-AF trial. 

OCEANIC-AF: Asundexian Patients Have Nearly 4x Stroke, Embolism Risk vs Apixaban Patients

HIIT exercise post-stroke improved aerobic fitness more than MICT, with significant gains in peak VO2 after 12 weeks.

HIIT Training Could Offer Greater Exercise Improvements During Stroke Rehabilitation

On the HCPLive stroke page, resources on the topics of medical news and expert insight into CVA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on stroke medicine, and more.